FDA: New Glucose Monitoring System Eliminates Finger Pricks

Share this content:
FDA: New Glucose Monitoring System Eliminates Finger Pricks
FDA: New Glucose Monitoring System Eliminates Finger Pricks

THURSDAY, Sept. 28, 2017 (HealthDay News) -- The FreeStyle Libre Flash Glucose Monitoring System has been approved by the U.S. Food and Drug Administration, making it the first sanctioned device to monitor blood glucose in adult patients with diabetes without the need for a finger prick.

The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose, the agency said in a news release. The new device does not produce any type of alarm or alert if blood glucose levels are inappropriate, the agency noted.

"This system allows people with diabetes to avoid the additional step of fingerstick calibration, which can sometimes be painful, but still provides necessary information for treating their diabetes," said Donald St. Pierre, acting director of the Office of In Vitro Diagnostics and Radiological Health and deputy director of new product evaluation in the FDA's Center for Devices and Radiological Health.

The system is produced by Abbott Diabetes Care, based in Alameda, California.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths